Coreg and Nosebleed - a phase IV clinical study of FDA data
Nosebleed is found among people who take Coreg, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Coreg and have Nosebleed. It is created by eHealthMe based on reports of 46,057 people who have side effects when taking Coreg from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
46,057 people reported to have side effects when taking Coreg.
Among them, 520 people (1.13%) have Nosebleed.
What is Coreg?
Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 47,429 Coreg users for its effectiveness, alternative drugs and more.
What is Nosebleed?
Nosebleed (bleeding from nose) is found to be associated with 3,241 drugs and 2,839 conditions by eHealthMe.
Number of Coreg and Nosebleed reports submitted per year:
Time on Coreg when people have Nosebleed *:
Gender of people who have Nosebleed when taking Coreg*:
Age of people who have Nosebleed when taking Coreg *:
Common drugs people take besides Coreg *:
Common side effects people have besides Nosebleed *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Coreg and have Nosebleed?Check whether Nosebleed is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
How severe was Nosebleed and when was it recovered:
Expand to all the drugs that have ingredients of carvedilol:
- Nosebleed and drugs with ingredients of carvedilol (1,406 reports)
Alternative drugs to, pros and cons of Coreg:
- Coreg (47,429 reports)
Common Coreg side effects:
- Breathing difficulty: 3,867 reports
- Fatigue (feeling of tiredness): 3,828 reports
- Weakness: 3,259 reports
- Dizziness: 3,204 reports
- Hypotension (abnormally low blood pressure): 2,982 reports
Browse all side effects of Coreg:a b c d e f g h i j k l m n o p q r s t u v w x y z
Nosebleed treatments and more:
- Nosebleed (81,912 reports)
COVID vaccines that are related to Nosebleed:
- Nosebleed in Moderna COVID Vaccine
- Nosebleed in Pfizer BioNTech Covid Vaccine
- Nosebleed in Johnson and Johnson Covid Vaccine
Common drugs associated with Nosebleed:
- Xarelto: 7,535 reports
- Aspirin: 6,510 reports
- Coumadin: 3,010 reports
- Prednisone: 2,977 reports
- Furosemide: 2,875 reports
- Eliquis: 2,609 reports
- Omeprazole: 2,589 reports
- Lasix: 2,551 reports
- Lisinopril: 2,400 reports
- Methotrexate: 2,303 reports
All the drugs that are associated with Nosebleed:
- Nosebleed (3,241 drugs)
Common conditions associated with Nosebleed:
- Atrial fibrillation/flutter: 6,500 reports
- Stroke: 4,890 reports
- High blood pressure: 3,909 reports
- Primary pulmonary hypertension: 3,089 reports
- Rheumatoid arthritis: 2,745 reports
- Pain: 1,900 reports
- High blood cholesterol: 1,796 reports
All the conditions that are associated with Nosebleed:
- Nosebleed (2,839 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carvedilol (the active ingredients of Coreg) and Coreg (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vaseretic vs. Isradipine - 8 seconds ago
- Opana vs. Tramadol Hydrochloride And Acetaminophen - 10 seconds ago
- Concerta and Antipsychotic Drug Level Increased - 10 seconds ago
- Vitamin C and Disinhibition - 12 seconds ago
- Hepatomegaly and johnson and johnson covid vaccine - 15 seconds ago
- Melatonin and Metoclopramide drug interaction - 15 seconds ago
- Claritin vs. Vistaril - 16 seconds ago
- Methocarbamol vs. Metaxalone - 18 seconds ago
- Tapentadol Hydrochloride vs. Oxecta - 19 seconds ago
- Sertraline Hydrochloride and Non-Alcoholic Steatohepatitis - 20 seconds ago